JAZZ vs BIIB: Which Stock is Better?
Side-by-side comparison of Jazz Pharmaceuticals Plc and Biogen Inc in 2026
JAZZ
Jazz Pharmaceuticals Plc
$203.42
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | JAZZ | BIIB | Winner |
|---|---|---|---|
| Market Cap | $12.52B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.1% | -0.1% | JAZZ |
| Gross Margin | 91.7% | 78.9% | JAZZ |
Analyze JAZZ
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JAZZ or BIIB a better investment?
Comparing JAZZ and BIIB: Jazz Pharmaceuticals Plc has a market cap of $12.52B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JAZZ and BIIB?
JAZZ (Jazz Pharmaceuticals Plc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JAZZ or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JAZZ or BIIB?
JAZZ has higher revenue growth at 0.1% vs -0.1% for BIIB.
Which company is more profitable: JAZZ or BIIB?
Jazz Pharmaceuticals Plc (JAZZ) has higher gross margins at 91.7% compared to 78.9% for BIIB.
Which is the larger company: JAZZ or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $12.52B for JAZZ.
Should I buy JAZZ or BIIB in 2026?
Both JAZZ and BIIB have investment merit. JAZZ trades at $203.42 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JAZZ and BIIB stock?
Key differences: Market Cap ($12.52B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.1% vs -0.1%), Gross Margin (91.7% vs 78.9%).